These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
514 related items for PubMed ID: 16635707
21. [Resistance of infectious agents involved in low respiratory tract infections in France]. Varon E, Houssaye S. Med Mal Infect; 2006; 36(11-12):555-69. PubMed ID: 16962730 [Abstract] [Full Text] [Related]
22. Antimicrobial treatment of lower respiratory tract infections in the hospital setting. Grossman RF, Rotschafer JC, Tan JS. Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675 [Abstract] [Full Text] [Related]
29. Appropriate antibiotic use in treating respiratory tract infections. Poole MD. Am J Manag Care; 2001 Jun; 7(6 Suppl):S178-82. PubMed ID: 11424586 [Abstract] [Full Text] [Related]
30. Resistant microorganisms in head and neck infections. Mazzulli T. J Otolaryngol; 2005 Jun; 34 Suppl 1():S2-6. PubMed ID: 16089233 [Abstract] [Full Text] [Related]
31. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. Biedenbach DJ, Jones RN, Fritsche TR. Diagn Microbiol Infect Dis; 2008 Jun; 61(2):240-4. PubMed ID: 18353594 [Abstract] [Full Text] [Related]
32. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles. Jacobs MR. Expert Rev Anti Infect Ther; 2005 Jun; 3(3):353-60. PubMed ID: 15954852 [Abstract] [Full Text] [Related]
38. Antimicrobial drug use and resistance among respiratory pathogens in the community. Low DE. Clin Infect Dis; 2001 Sep 15; 33 Suppl 3():S206-13. PubMed ID: 11524720 [Abstract] [Full Text] [Related]
39. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN, Sader HS, Stilwell MG, Fritsche TR. Diagn Microbiol Infect Dis; 2007 May 15; 58(1):1-7. PubMed ID: 17408904 [Abstract] [Full Text] [Related]
40. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use. Cizman M, Beović B, Seme K, Paragi M, Strumbelj I, Müller-Premru M, Cad-Pecar S, Pokorn M. Int J Antimicrob Agents; 2006 Dec 15; 28(6):537-42. PubMed ID: 17101264 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]